Clinical Trials Browser

Unknown × Non-small Cell Lung Cancer Metastatic × pembrolizumab × Clear all

NCT03656094 2019-12-09

Chemotherapy With Pembrolizumab Continuation After Progression to PD-1/L1 Inhibitors

Phase 2 Unknown

Non-small Cell Lung Cancer Metastatic